-
公开(公告)号:US09957320B2
公开(公告)日:2018-05-01
申请号:US15180916
申请日:2016-06-13
Applicant: UCB BIOPHARMA SPRL
Inventor: Neil Gozzard , Alastair David Griffiths Lawson , Daniel John Lightwood , Roger Thomas Palframan , Bryan John Smith , Kerry Louise Tyson
IPC: C07K16/24 , A61K39/395 , A61K9/00 , A61K39/00
CPC classification number: C07K16/244 , A61K9/0078 , A61K39/395 , A61K39/3955 , A61K2039/505 , A61K2039/544 , C07K2317/24 , C07K2317/33 , C07K2317/51 , C07K2317/515 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92 , C07K2317/94
Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of human IL-13, therapeutic uses of the antibody molecules and methods for producing antibody molecules.
-
2.ANTIBODY MOLECULES HAVING BINDING SPECIFICITY FOR HUMAN IL-13 有权
Title translation: 具有人IL-13结合特异性的抗体分子公开(公告)号:US20160289323A1
公开(公告)日:2016-10-06
申请号:US15180916
申请日:2016-06-13
Applicant: UCB BIOPHARMA SPRL
Inventor: Neil Gozzard , Alastair David Griffiths Lawson , Daniel John Lightwood , Roger Thomas Palframan , Bryan John Smith , Kerry Louise Tyson
IPC: C07K16/24 , A61K9/00 , A61K39/395
CPC classification number: C07K16/244 , A61K9/0078 , A61K39/395 , A61K39/3955 , A61K2039/505 , A61K2039/544 , C07K2317/24 , C07K2317/33 , C07K2317/51 , C07K2317/515 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92 , C07K2317/94
Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of human IL-13, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
Abstract translation: 本发明涉及对人IL-13的抗原决定簇具有特异性的抗体分子,抗体分子的治疗用途以及产生所述抗体分子的方法。
-